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ABSTRACT
Objective: The aim of the study was to evaluate whether Vernonia cinerea (VC) regenerates the proximal renal tubular cells in cisplatin-induced 
necrosis in male Swiss albino mice.
Methods: The crude aqueous extract (CAE) of VC was fractionated from non-polar to polar using different solvents. Mice were injected a single dose 
of cisplatin (15 mg/kg) on day 1, which took 5 days to cause maximal renal damage. From day 6, CAE and all fractions were orally administered (200, 
300, and 400 mg/kg) for 5 continuous days. On day 11, blood was collected to estimate urea and creatinine. Kidney was collected for histology and 
grading was done.
Results: Cisplatin induced proximal renal tubular damage (grade 5) in corticomedullary junction, characterized by necrosis, proximal tubular 
dilatation, inflammation and vasodilation. Aqueous fraction (AF) did not show any regeneration; whereas, 400 mg/kg dose of CAE and butanol fraction 
(BF) showed a significant reduction (p<0.001) in proximal tubular damage (Grade 3) and 50–75% regeneration of proximal tubular epithelial cells.
Conclusion: This is the first study to demonstrate the regenerative potential of Neichitti kashayam (CAE of VC) and its BF in cisplatin-induced proximal 
tubular damage in kidney. Further study is warranted to find out the dose regimen for complete regeneration, lead compounds, and molecular 
mechanism.
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INTRODUCTION
Cisplatin is an anticancer drug used in the treatment of solid organ 
cancers such as cervical, squamous cell carcinoma of head and neck, 
ovarian, testicular, bladder and lung cancers. It gets accumulated about 
5 times the serum concentration in renal tubular epithelial cells; thus, 
the chances for nephrotoxicity are higher during cisplatin therapy. 
There are many reports on lack of recovery, progressive and permanent 
nephrotoxicity with successive treatment with cisplatin [1-3]. Risk factors 
for cisplatin nephrotoxicity include older age, smoking, dose, frequency, 
cumulative dose, pre-existing renal impairment, female gender, and 
hypoalbuminemia [2,3]. Cisplatin-induced inflammatory responses, 
damage to mitochondrial and nuclear DNA and reactive oxygen species 
lead to activation of both mitochondrial and non-mitochondrial apoptosis 
and necrosis in renal epithelial cells. Since the anticancer mechanism is 
responsible for the cisplatin-induced proximal tubular damage, strategies 
to treat should not compromise the anti-tumor activity of cisplatin [4].
No drugs have been approved by FDA to regenerate the renal tubular 
cells in cisplatin-induced renal damage. Many medicinal plants such 
as Catunaregam uliginosa, Mentha arvensis, Allium sativum, and Bassia 
malabarica have been studied for cisplatin-induced nephroprotective 
action [4-7]. Vernonia cinerea (VC) whole plant is used in traditional 
medicines to treat renal calculi, herpes, diarrhea, stomach pain, eczema, 
elephantiasis, cough, inflammations, skin diseases, fevers, ringworm, 
and conjunctivitis [8,9]. Different extracts of VC have been demonstrated 
for antioxidant, antipyretic, antidiarrhoea and anti-inflammatory 
properties. It downregulates pro-inflammatory cytokines [10-14].
Traditional Siddha Medicine literature suggests using VC decoction 
(polar crude aqueous extract [CAE]) to recover internal organ damage 
caused by metals and drugs [15]. The preliminary study with VC against 
sub-therapeutic dose of cisplatin (6 mg/kg) was evaluated using non-
polar extracts (petroleum ether, ethyl acetate, and alcoholic extract) 
and concluded that the plant improves renal function [16]. However, 
the therapeutic effect of VC on kidney was not been asserted through 
histopathology. None of the previous studies have assessed the 
regenerative potential of VC in damaged kidney caused by cisplatin. 
Therefore, this study was aimed to evaluate the therapeutic potential 
of VC in cisplatin-induced nephrotoxicity at dose extrapolated from the 
human dose and to assert this potential through histopathology.
METHODS
Plant collection, extraction, and fractionation
VC was collected from our institution campus, authenticated by a 
Taxonomy Expert from SDM Centre for Research in Ayurveda and 
Allied Sciences, Udupi, Karnataka, India, and the Voucher specimen 
was preserved (no. 604.15042404). The CAE of the whole plant was 
prepared by cold maceration method. Further fractionation was done 
using separating funnel by different solvents such as petroleum ether, 
chloroform, ethyl acetate, n-butanol, ethanol, and water.
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Laboratory animals
The study protocol was approved by Institutional Animal Ethics 
Committee, Kasturba Medical College, Manipal (Approval no: IAEC/
KMC/08/2014). Healthy adult male Swiss albino mice weighing between 
27 and 37 g were used. Animals were housed in standard environmental 
condition (temperature 27±3°C, photoperiod: Approximately 12 h 
natural light per day; relative humidity: 60±10%) and fed with diets 
and water ad libitum. The mice were housed in polycarbonate cages, 
provided with standard mice food and filtered water. All mice were 
made to adapt to the housing conditions 1 week before the study.
Study design and treatment
Renal damage was induced by single intraperitoneal cisplatin injection 
(15 mg/kg, i.p) on day 1 [17]. Totally, we had 11 groups with six mice in 














The extract and fractions were administered orally for 5 days from day 
6 to day 10. These three doses have been chosen based on acute toxicity 
study.
Parameters assessed
Body weight was assessed daily. On day 11, all the animals were 
anesthetized, and blood was collected. Blood urea, blood urea nitrogen 
(BUN), and creatinine were estimated from the plasma using the 
protocol provided by the Agappe Chemicals, India. The right kidney 
was collected from each animal for H and E histological assessment. 
The histology interpretation was done by the pathologist in the blinded 
slides. Histological scoring of renal tubular epithelial necrosis was done 
with mild modification from earlier scoring as follows; 0 = normal, 
1 = up to 10% renal tubular epithelial (mild) necrosis, 2 = 10–25% 
renal tubular epithelial (moderate) necrosis, 3 = 26–50% renal tubular 
epithelial (moderate to severe) necrosis, 4 = 51–75% renal tubular 
epithelial (severe) necrosis, and 5 = 76–100% renal tubular epithelial 
(very severe/extensive) necrosis [18].
Statistical analysis
All the data were expressed in mean ± SD. The data were analyzed using 
SPSS 11.0 version by one-way ANOVA followed by Dunnett’s post hoc 
test. p<0.05 was set as statistically significant.
RESULTS
Extraction and fractionations
The yield of CAE, BF, and AF of VC was 8.0, 18.6, and 81.4% w/w, 
respectively. The qualitative phytochemical analysis showed the 
presence of carbohydrate, steroid, and saponin in CAE and BF; whereas 
the AF lacked saponins.
Animal death
Mice that developed diarrhea eventually died within the next 3 days. 
Most of the animals from 200 mg/kg to 300 mg/kg dose groups were not 
survived, which revealed that the lower doses (200 and 300 mg/kg) were 
not able to protect the mice from cisplatin-induced toxicity (Table 1). 
Hence, normal control, cisplatin control, and 400 mg/kg doses of CAE, 
BF, and AF were considered for further evaluation of the blood and 
histology parameters.
Body weight
There was a weight gain in normal mice, whereas cisplatin injection 
significantly (p<0.05) reduced the body weight. Treatment with VC 
from day 6–10 did not improve weight, but the weight remained stable 
from day 6 to day 11 (Fig. 1).
Blood parameters
The elevated levels of serum urea and BUN due to cisplatin-induced 
renal damage significantly (p<0.001) continued even on day 11. The 
CAE did not reduce the elevated urea and BUN, whereas the BF and 
AF reduced the elevated urea and BUN, but this was not statistically 
significant. In addition, the creatinine level was normalized in cisplatin 
group spontaneously and in BF and AF treated groups after the 11th day 
of cisplatin injection (Figs. 2 and 3). These parameters tell the general 
renal function, not the cisplatin specific toxicity, which is assessed by 
histology of kidney.
Fig. 1: The body weight changes due to cisplatin and Vernonia cinerea extract/fraction treatment. All values are expressed in mean ± SD, 
n=6 in each group, cispl - cisplatin 15 mg/kg, CAE - crude aqueous extract, BF - butanol fraction, AF - aqueous fraction
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Histopathology of kidney
The glomerulus and distal tubules were not disturbed by cisplatin. 
The nephron damage was not observed in the outer cortex or 
inner medullary region, but the maximum damage was observed in 
corticomedullary junction area. 75–85% of proximal tubular had 
damaged in corticomedullary junction in cisplatin-treated group 
which was characterized by necrosis, proximal tubules dilatation, 
inflammation, and vasodilation. Similar changes were observed in 
AF treated group; whereas, in CAE and BF treated groups, 25–50% of 
proximal tubular had damaged. In addition, CAE and BF had induced 
regeneration in 50–75% of proximal tubular epithelial cells. The 
histological renal damage grade was significantly (p<0.001) lower in 
the crude aqueous extract as well as BF treated groups compared to 
cisplatin alone (Figs. 4 and 5).
DISCUSSION
Various Indian herbals such as Caesalpinia bonduc, Momordica dioica, 
and Morinda citrifolia have been reported for its renal protective effect 
against cisplatin [19,20]. VC is being used in Siddha Medicine to recover 
internal organ damage caused by metals and drugs. This property 
could be used to recover kidneys from cisplatin-induced toxicity in 
cancer patients. In our study, we used decoction (CAE) of VC and its two 
fractions to evaluate the property of recovering kidney from cisplatin-
induced toxicity in mice.
Nephrotoxicity was induced by injecting a single dose of cisplatin 
(15 mg/kg) intraperitoneally. Low doses (200 and 300 mg/kg) of 
VC extract/fractions did not recover the cisplatin-induced toxicity; 
whereas 400 mg/kg treatment did. The herbal extracts/fractions 
did not significantly increase the body weight in mice with cisplatin-
induced weight reduction.
Table 1: Number of animals died due to cisplatin toxicity















Fig. 2: Urea and blood urea nitrogen in mice with cisplatin-
induced nephrotoxicity and treated with Vernonia cinerea 
aqueous extract, butanol fraction, and water fraction. All 
values are expressed in mean ± SD, n=6 in each group, cisplatin 
- cisplatin 15 mg/kg, CAE - crude aqueous extract, BF - butanol 
fraction, AF - aqueous fraction
Fig. 3: Creatinine in mice with cisplatin-induced nephrotoxicity 
and treated with Vernonia cinerea aqueous extract, butanol 
fraction, and water fraction. All values are expressed in mean ± 
SD, n=6 in each group, cisplatin - cisplatin 15 mg/kg, CAE - crude 
aqueous extract, BF - butanol fraction, AF - aqueous fraction
Fig. 4: Effect of Vernonia cinerea extract and fractions on cisplatin-
induced renal necrosis. All values are expressed in mean ± SD, 
n=6 in each group, cisplatin - cisplatin 15 mg/kg, CAE - crude 
aqueous extract, BF - butanol fraction, AF - aqueous fraction
Fig. 5: Histology of kidney with cisplatin-induced nephrotoxicity 
and treated with Vernonia cinerea aqueous extract, butanol 
fraction, and water fractions (×10). (a) Normal kidney shows 
normal glomerulus, proximal tubules, distal tubules, and 
vasculature, (b) cisplatin injection damaged 75–85% of proximal 
tubules in cortico-medullary junction characterized by necrosis, 
proximal tubular dilatation, inflammation, and vasodilation, 
(c and d) crude aqueous extract and BF treated groups with 
reduction in the proximal tubular damage and 50–75% 
regeneration in proximal tubular cells, (e) aqueous fraction with 
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The renal histology is an important tool to assess the renal recovery 
state. In this study, the histology revealed that cisplatin did not 
damage the glomerulus. Damage specifically to proximal tubules 
in the corticomedullary junction could be due to the 5 times higher 
accumulation of cisplatin [1]. Even after 11 days post-injection, the 
cisplatin-induced proximal renal tubular damage persisted as apoptosis, 
necrosis, loss of epithelial cells in proximal tubule, dilatation of proximal 
tubules, vasodilation, and inflammatory infiltration. The extent of 
tubular necrosis caused by cisplatin was graded as 5 (75–85% tubular 
necrosis), which was significantly reduced to Grade 3 (25–50%) by CAE 
(Neichitti kashayam) and BF, and both of them also showed additional 
regeneration (50–75%) of proximal tubular epithelial cells. The recovery 
of renal tubules with tubular cells regeneration in cisplatin-induced renal 
damage by the herbal paves the way for drug discovery. In this study, 
there was no complete reversal from damage, which could be achieved 
probably by long-term treatment or higher doses or earlier intervention. 
No previous studies have evaluated the proximal renal cell regeneration 
activity of VC. This is the first study to show the regenerative ability of VC 
in renal tubules.
Antioxidant and anti-inflammatory actions of VC by reducing IL-6 level 
through an inhibition of BF-KB nuclear translocation might be the possible 
mechanisms behind the reduction in proximal tubular necrosis [21,22].
The major phytoconstituents of VC include lupeol, lupeol acetate, luteolin-7-
O-glucoside,	stigmasterol-β-D-glucopyranoside,	β-amyrin,	stigmasterol,	and	
dotriacontanoic	acid.	Other	minor	phytochemicals	are	 luteolin,	α-amyrin,	
lupeol palmitate, isoorientin, luteolin-7-O-glucuronide, diosmetin, 
chrysoeriol,	 β-amyrin	 acetate,	 α-amyrin	 acetate,	 α-amyrin	 palmitate,	
δ-amyrin	 acetate,	 26-methylheltacosanoic	 acid,	 stigmast-5,17(20)-dien-
3β-ol,	 campersterol,	 3β-acetoxyurs-13(18)-ene,	 3β-acetoxyurs-19-ene,	
24-hydroxy	taraxer-14-ene,	α-spinasterol,	β-sitosterol,	and	sitosterol	[23].	
The recovery of kidney with proximal tubular epithelial regeneration in 
cisplatin-induced renal damage could be due to these phytochemicals. 
However, further studies to be carried out to identify the lead compound.
CONCLUSION
N. kashayam (CAE of VC) and its BF have shown significant recovery 
with cell regeneration in cisplatin-induced proximal tubular damage in 
kidney. This is the first study to give scientific support for traditional 
Siddha practice and demonstrate the regenerative potential of this 
plant. BF of VC is the potent candidate for drug discovery to recover 
kidney damage during cisplatin therapy among cancer patients. Further 
study is warranted to find the dose regimen for complete regeneration, 
lead compounds, and the molecular mechanism.
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